LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

Search

ICU Medical Inc

Geschlossen

BrancheGesundheitswesen

132.32 -0.81

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

130.62

Max

134.36

Schlüsselkennzahlen

By Trading Economics

Einkommen

-39M

-3.4M

Verkäufe

-12M

537M

Gewinnspanne

-0.632

Angestellte

15,000

EBITDA

-40M

67M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+27.86% upside

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

288M

3.3B

Vorheriger Eröffnungskurs

133.13

Vorheriger Schlusskurs

132.32

Nachrichtenstimmung

By Acuity

50%

50%

177 / 374 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bullish Evidence

ICU Medical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

19. Nov. 2025, 23:36 UTC

Heiße Aktien

Stocks to Watch: Nvidia, Kulicke & Soffa, Regeneron

19. Nov. 2025, 22:13 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Palo Alto Networks to Buy Chronosphere for $3.35 Billion, Posts Higher 1Q Revenue -- Update

19. Nov. 2025, 21:55 UTC

Wichtige Markttreiber

Amgen Lung Cancer Drug Gets Full Approval From FDA

19. Nov. 2025, 21:43 UTC

Akquisitionen, Fusionen, Übernahmen

Palo Alto Networks to Buy Chronosphere for $3.35 Billion

19. Nov. 2025, 23:55 UTC

Market Talk

Gold Rises on Possible Investment Demand -- Market Talk

19. Nov. 2025, 23:54 UTC

Market Talk

BHP Vicuna JV Offers Significant Copper Output, At a Cost -- Market Talk

19. Nov. 2025, 23:47 UTC

Ergebnisse

Lenovo Group 2Q EPS $2.52 >0992.HK

19. Nov. 2025, 23:46 UTC

Ergebnisse

Lenovo Group: Delivered Double-Digit Yr-on-Yr Rev Growth Across All Main Business Groups and Sales Geographies >0992.HK

19. Nov. 2025, 23:45 UTC

Ergebnisse

Lenovo Group 2Q Rev $20.5B >0992.HK

19. Nov. 2025, 23:42 UTC

Market Talk

Nikkei May Rise After Nvidia's Strong Earnings Soothe Investors' Nerves -- Market Talk

19. Nov. 2025, 23:42 UTC

Market Talk

Global Equities Roundup: Market Talk

19. Nov. 2025, 23:41 UTC

Ergebnisse

Lenovo Group 2Q Adj Net $512.0M Vs. $409.0M >0992.HK

19. Nov. 2025, 23:41 UTC

Ergebnisse

Lenovo Group 2Q Net $340.0M Vs. Net $359.0M >0992.HK

19. Nov. 2025, 23:40 UTC

Ergebnisse

Lenovo Group 2Q Rev $20.45B Vs. $17.85B >0992.HK

19. Nov. 2025, 22:55 UTC

Ergebnisse

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 4th Update

19. Nov. 2025, 22:41 UTC

Ergebnisse

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 3rd Update

19. Nov. 2025, 22:30 UTC

Akquisitionen, Fusionen, Übernahmen

CICC Seeks Trading Halt in Hong Kong, Shanghai Stock Exchange

19. Nov. 2025, 22:30 UTC

Ergebnisse

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 2nd Update

19. Nov. 2025, 22:30 UTC

Akquisitionen, Fusionen, Übernahmen

CICC Plans to Acquire Brokerage Firms via Share-Swap Agreement

19. Nov. 2025, 22:27 UTC

Akquisitionen, Fusionen, Übernahmen

China International Capital Plans to Acquire Brokerage Firms Cinda Securities, Dongxing Securities

19. Nov. 2025, 22:08 UTC

Ergebnisse

ZTO Express (Cayman) 3Q Rev $1.67B >ZTO

19. Nov. 2025, 22:00 UTC

Ergebnisse

Investors Cheer Blockbuster Nvidia Earnings -- WSJ

19. Nov. 2025, 21:58 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Palo Alto Networks to Buy Chronosphere for $3.35B, Posts Higher 1Q Rev -- Update

19. Nov. 2025, 21:52 UTC

Ergebnisse

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- Update

19. Nov. 2025, 21:50 UTC

Market Talk
Ergebnisse

Tech, Media & Telecom Roundup: Market Talk

19. Nov. 2025, 21:49 UTC

Market Talk
Ergebnisse

Nvidia Quiets Investor Fears With Ballooning Demand -- Market Talk

19. Nov. 2025, 21:38 UTC

Ergebnisse

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- WSJ

19. Nov. 2025, 21:28 UTC

Akquisitionen, Fusionen, Übernahmen

Palo Alto Networks to Buy Chronosphere for $3.35B

19. Nov. 2025, 21:27 UTC

Akquisitionen, Fusionen, Übernahmen

Exact Sciences Stock Jumps on Reported Deal Interest from Abbott Laboratories -- Barrons.com

19. Nov. 2025, 21:24 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Palo Alto Networks 1Q Next-Generation Security ARR $5.9 B >PANW

Peer-Vergleich

Kursveränderung

ICU Medical Inc Prognose

Kursziel

By TipRanks

27.86% Vorteil

12-Monats-Prognose

Durchschnitt 172 USD  27.86%

Hoch 172 USD

Tief 172 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für ICU Medical Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

3 ratings

2

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

137.16 / N/AUnterstützung & Widerstand

Kurzfristig

Very Strong Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Strong Bearish Evidence

Stimmung

By Acuity

177 / 374 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über ICU Medical Inc

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
help-icon Live chat